Laparoscopic gastroenterostomy for duodenal obstruction*
References (13)
Nonsurgical palliation of jaundice in pancreatic cancer
Surg Clin North Am
(1989)- et al.
Surgical palliation for pancreatic cancer
Surg Clin North Am
(1989) Laparoscopic cholecyst-jejunostomy and gastroenterostomy for malignant disease
Surg Oncol
(1993)Bypass surgery for malignant low bile duct obstruction
- et al.
Sutured laparoscopic cholecysto-jejunostomy evolved in an animal model
J R Coll Surg Edinb
(1992) - et al.
Laparoscopy in the management of pancreatic cancer: endoscopic cholecystojejunostomy for advanced disease
Br J Surg
(1992)
Cited by (70)
Endoscopic intestinal bypass creation by using self-assembling magnets in a porcine model
2016, Gastrointestinal EndoscopyMetallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients
2007, Gastrointestinal EndoscopyCitation Excerpt :In comparison, open palliative surgery was associated with high mortality and morbidity rates (8%-33% and 20%-60%, respectively)16-20 and long length of hospital stay (14 days vs 4 days for stenting).21 Laparoscopic palliative surgery has recently been introduced as a minimally invasive surgical technique; however, it takes a long time to regain gut function postoperatively, and the need for surgical conversion is approximately 20%.22 These facts provide strong evidence favoring this form of nonsurgical palliative therapy in patients with unresectable malignant gastroduodenal obstruction.
Malignant Gastroenteric Obstruction: Therapeutic Options
2007, Gastrointestinal Endoscopy Clinics of North AmericaCitation Excerpt :The major shortcomings of surgical GEA, both open and laparoscopic, include significant rates of morbidity and mortality, which can be as high as 30% and 15%, respectively. In addition, postoperative ileus leading to hospital stays of 2 weeks or more and delayed gastric emptying can have a significant negative impact on the quality of life of individuals undergoing this procedure [2,9,10,13]. SEMS placement (using an esophageal stent) for palliation of malignant gastric outlet obstruction was first reported in 1992 by Truong and colleagues.
Minimally Invasive Treatment of Pancreatic Disease
2007, Gastroenterology Clinics of North AmericaCitation Excerpt :The safety and effectiveness of a laparoscopic stapled gastrojejunostomy has been shown in several series of patients with malignant gastric outlet obstruction, and in the vast experience with laparoscopic gastric bypass surgery. It should be considered together with endoluminal stenting as an alternative to an open surgical bypass procedure [30–35]. Finally, even among patients deemed not to be candidates for surgical resection by virtue of locally advanced disease found on routine imaging studies, laparoscopy may provide more accurate staging and determine whether systemic therapy should be administered alone or in combination with locoregional therapy [36,37].
- *
Presented at the 81st Annual Meeting of the North Pacific Surgical Association, Coeur d'Alene, Idaho, November 10–11, 1994.